Allison Luo

Allison Luo, MD is currently the Chief Medical Officer at Mirador Therapeutics and serves as a Member of the Board of Directors at Triveni Bio. With a background as the Chief Medical Officer at various pharmaceutical and biotech companies such as Prometheus Biosciences, Inc., OPPILAN PHARMA LIMITED (now Ventyx Biosciences), and Escalier Biosciences B.V., Allison brings a wealth of experience to their current roles. Prior to their current positions, Allison held leadership roles at Progenity, Inc., Ophthotech Corporation, Bristol Myers Squibb, and Abbott. Allison obtained their Doctor of Medicine degree from Northwestern University - The Feinberg School of Medicine and a Bachelor of Science in Biochemistry from Northwestern University.